Garcia-De-Albeniz XA. Effectiveness of screening colonoscopy to prevent colorectal cancer among Medicare beneficiaries aged 70 to 79 years - behind the scenes. Presented at the Winter 2017 Epidemiology Seminar Series at McGill University's Department of Epidemiology, Biostatistics and Occupational Health; February 20, 2017. Montreal, Canada. Previously presented at the 2017 Program on Biostatistics for Cancer Research at Harvard T.H. Chan School of Public Health.


SYNOPSIS: No randomized, controlled trials of screening colonoscopy have been completed, and ongoing trials exclude persons aged 75 years or older. The Medicare program, however, reimburses screening colonoscopy without an upper age limit. We evaluated the effectiveness and safety of screening colonoscopy to prevent colorectal cancer (CRC) in persons aged 70 to 74 and those aged 75 to 79 years. We used observational data to emulate a target trial with 2 groups: colonoscopy screening and no screening. This talk will provide an overview of the motivation, implementation and methodological challenges faced in implementing this study.

Share on: